Medtronic’s initial payment for the acquisition was $150 million in cash. Other terms of the acquisition were not disclosed.
“Medtronic is committed to fighting stroke through the innovative therapies we bring to clinicians and patients. Medina Medical’s breakthrough technology makes it a antural fit with our Neurovascular portfolio, further strengthening our hemorrhagic stroke portfolio,” said Brett Wall, president of Medtronic’s neurovascular division.
More articles on health IT:
More than $31B distributed in MU payments to date
Hillary Clinton brings telemedicine into the political conversation
9 recent vendor contracts, go-lives
